| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $493K | — | +1.6% |
| Cost of Revenue | $155K | — | -9.9% |
| Gross Profit | $338K | — | +8.0% |
| R&D Expense | $422K | — | +1.0% |
| SG&A Expense | $2.0M | — | +30.6% |
| Operating Income | -$2.1M | — | -27.4% |
| Interest Expense | $4K | — | -20.0% |
| Net Income | -$2.1M | — | -23.9% |
| EPS (Basic) | -$0.39 | — | +69.5% |
| EPS (Diluted) | -$0.39 | — | +69.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.8M | -10.2% | +311.1% |
| Short-term Investments | $0 | -100.0% | — |
| Accounts Receivable | $163K | -18.9% | -67.3% |
| Inventory | $1.0M | +5.4% | +39.2% |
| Current Assets | $8.4M | -17.0% | +164.0% |
| Total Assets | $11.1M | -13.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.9M | — | -23.9% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $1.0M | — | +2877.8% |
| Financing Cash Flow | $158K | — | -91.9% |
| Free Cash Flow | -$1.9M | — | -21.1% |
| +205.1% |
| Current Liabilities | $938K | +17.5% | +72.7% |
| Total Liabilities | $3.4M | +2.7% | +358.0% |
| Stockholders' Equity | $7.7M | -19.5% | +166.3% |